105 related articles for article (PubMed ID: 12227184)
1. [Immune control of HIV-infection and replication].
Matsushita S
Uirusu; 2002 Jun; 52(1):77-82. PubMed ID: 12227184
[No Abstract] [Full Text] [Related]
2. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
Emini EA; Koff WC
Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
[No Abstract] [Full Text] [Related]
3. [Update on HIV pathogenesis].
Detres LL
Sidahora; 1995; ():13-4. PubMed ID: 11363197
[TBL] [Abstract][Full Text] [Related]
4. Cellular immune responses to HIV.
McMichael AJ; Rowland-Jones SL
Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
[TBL] [Abstract][Full Text] [Related]
5. To kill or be killed: how HIV exhausts the immune system.
Gougeon ML
Cell Death Differ; 2005 Aug; 12 Suppl 1():845-54. PubMed ID: 15832178
[No Abstract] [Full Text] [Related]
6. HIV pathogenesis: the first cut is the deepest.
Picker LJ; Watkins DI
Nat Immunol; 2005 May; 6(5):430-2. PubMed ID: 15843796
[No Abstract] [Full Text] [Related]
7. Control of HIV despite the discontinuation of antiretroviral therapy.
Lisziewicz J; Rosenberg E; Lieberman J; Jessen H; Lopalco L; Siliciano R; Walker B; Lori F
N Engl J Med; 1999 May; 340(21):1683-4. PubMed ID: 10348681
[No Abstract] [Full Text] [Related]
8. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.
Jaye A; Sarge-Njie R; Schim van der Loeff M; Todd J; Alabi A; Sabally S; Corrah T; Whittle H
J Infect Dis; 2004 Feb; 189(3):498-505. PubMed ID: 14745708
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?
Grossman Z; Meier-Schellersheim M; Sousa AE; Victorino RM; Paul WE
Nat Med; 2002 Apr; 8(4):319-23. PubMed ID: 11927927
[No Abstract] [Full Text] [Related]
10. [Prognostic indices for the course of HIV infection].
Hess G
Verh Dtsch Ges Inn Med; 1991; 97():386-90. PubMed ID: 1687300
[No Abstract] [Full Text] [Related]
11. The dynamics of CD4+ T-cell depletion in HIV disease.
McCune JM
Nature; 2001 Apr; 410(6831):974-9. PubMed ID: 11309627
[TBL] [Abstract][Full Text] [Related]
12. Th17 cells, HIV and the gut mucosal barrier.
Dandekar S; George MD; Bäumler AJ
Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
[TBL] [Abstract][Full Text] [Related]
13. Managing HIV. Part 3. Mechanisms of disease. 3.2 How HIV produces immune deficiency.
Ffrench R; Stewart GJ; Penny R; Levy JA
Med J Aust; 1996 Feb; 164(3):166-71. PubMed ID: 8628137
[TBL] [Abstract][Full Text] [Related]
14. HIV-specific CD4+ T cells and viremia: who's in control?
Jansen CA; van Baarle D; Miedema F
Trends Immunol; 2006 Mar; 27(3):119-24. PubMed ID: 16458605
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of HIV.
Kaplan MH
Infect Dis Clin North Am; 1994 Jun; 8(2):279-88. PubMed ID: 7916357
[TBL] [Abstract][Full Text] [Related]
16. Immune activation and the pathogenesis of HIV disease: implications for therapy.
Fernandez S; Lim A; French M
J HIV Ther; 2009 Nov; 14(3):52-6. PubMed ID: 20218239
[No Abstract] [Full Text] [Related]
17. [Current advances in HIV pathogenesis. Results of therapy and vaccine development].
Wagner R; Mayer J; Wolf H
Dtsch Med Wochenschr; 1995 May; 120(20):728-36. PubMed ID: 7758413
[No Abstract] [Full Text] [Related]
18. Chromosome instability: lessons from HIV.
Medema JP; Medema RH
Nat Cell Biol; 2002 Aug; 4(8):E191-3. PubMed ID: 12149628
[No Abstract] [Full Text] [Related]
19. The value of preserving HIV-specific immune responses.
Kaufmann DE; Rosenberg ES
J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
[TBL] [Abstract][Full Text] [Related]
20. Endocytosis of HIV: anything goes.
Permanyer M; Ballana E; Esté JA
Trends Microbiol; 2010 Dec; 18(12):543-51. PubMed ID: 20965729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
